FDA
approval
· 2018-05-18
FDA Approved: ACZONE — Supplemental Application (Almirall, LLC)
Summary
The FDA approved a supplemental application for ACZONE (dapsone) submitted by Almirall, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ACZONE (DAPSONE)